Literature DB >> 19809562

The role of radiotherapy in the treatment of newly diagnosed supratentorial low-grade oligodendrogliomas: comparative analysis with immediate radiotherapy versus surgery alone.

Hyun-Cheol Kang1, Il Han Kim, Keun-Yong Eom, Jin Ho Kim, Hee-Won Jung.   

Abstract

PURPOSE: The purpose of this study was to evaluate the role of immediate postoperative radiotherapy (RT) in adult patients with a low-grade oligodendroglioma (LODG).
MATERIALS AND METHODS: A total of 74 patients, older than 15 years, were treated in our institution between April 1990 and March 2006 for newly diagnosed LODGs. After surgery, 43 patients were treated with immediate RT with a total dose of 54~55.8 Gy with 1.8 Gy fractions (RT group) and 31 patients were followed with no adjuvant RT (OP group). All patients were closely observed until tumor progression or death with frequent work-ups including neurological examinations and MRI. Primary endpoints were overall survival and progression-free survival. The median follow-up duration of survivors was 6.2 years in the RT group and 5.8 years in the OP group.
RESULTS: Median progression-free survival was 13.2 years in the RT group and 4.6 years in the OP group; multivariate analysis confirmed improved outcome with the use of immediate RT (hazard ratio, 0.22; 95% confidence interval-CI, 0.09~0.55; p<0.001). Median overall survival was 14.9 years in the RT group and 9.8 years in the OP group; the use of adjuvant RT was also associated with a trend toward better overall survival after immediate RT based on multivariate analysis (hazard ratio, 0.3; 95% CI, 0.08~1.17; p=0.082). No severe RT related complications were observed.
CONCLUSION: Immediate RT following surgery appears to be an effective treatment modality for supratentorial LODGs. However, the potential benefit of adjuvant RT for overall survival needs to be tested prospectively in the future.

Entities:  

Keywords:  Brain neoplasms; Oligodendroglioma; Radiotherapy

Year:  2009        PMID: 19809562      PMCID: PMC2757663          DOI: 10.4143/crt.2009.41.3.132

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN: 1598-2998            Impact factor:   4.679


  23 in total

1.  Oligodendroglioma: an analysis of prognostic factors and treatment results.

Authors:  A Allam; A Radwi; A El Weshi; M Hassounah
Journal:  Am J Clin Oncol       Date:  2000-04       Impact factor: 2.339

2.  Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases.

Authors:  C Daumas-Duport; P Varlet; M L Tucker; F Beuvon; P Cervera; J P Chodkiewicz
Journal:  J Neurooncol       Date:  1997-08       Impact factor: 4.130

3.  The role of postoperative irradiation in the treatment of oligodendroglioma.

Authors:  D E Gannett; W M Wisbeck; D L Silbergeld; M S Berger
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-10-15       Impact factor: 7.038

4.  Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study.

Authors:  E Shaw; R Arusell; B Scheithauer; J O'Fallon; B O'Neill; R Dinapoli; D Nelson; J Earle; C Jones; T Cascino; D Nichols; R Ivnik; R Hellman; W Curran; R Abrams
Journal:  J Clin Oncol       Date:  2002-05-01       Impact factor: 44.544

5.  Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study.

Authors:  M Klein; J J Heimans; N K Aaronson; H M van der Ploeg; J Grit; M Muller; T J Postma; J J Mooij; R H Boerman; G N Beute; G J Ossenkoppele; G W van Imhoff; A W Dekker; J Jolles; B J Slotman; H Struikmans; M J B Taphoorn
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

6.  Treatment outcomes and prognostic factors of patients with supratentorial low-grade oligodendroglioma.

Authors:  Shyh-An Yeh; Tao-Chen Lee; Han-Jung Chen; Chun-Chung Lui; Li-Min Sun; Chong-Jong Wang; Eng-Yen Huang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-12-01       Impact factor: 7.038

7.  Prognostic factors in oligodendroglioma.

Authors:  D Schiffer; A Dutto; P Cavalla; I Bosone; A Chiò; R Villani; C Bellotti
Journal:  Can J Neurol Sci       Date:  1997-11       Impact factor: 2.104

8.  Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group.

Authors:  G M Kiebert; D Curran; N K Aaronson; M Bolla; J Menten; E H Rutten; E Nordman; M E Silvestre; M Pierart; A B Karim
Journal:  Eur J Cancer       Date:  1998-11       Impact factor: 9.162

9.  Oligodendroglioma: does deferring treatment compromise outcome?

Authors:  Steven J Feigenberg; Robert J Amdur; Christopher G Morris; William M Mendenhall; Robert B Marcus; William A Friedman
Journal:  Am J Clin Oncol       Date:  2003-06       Impact factor: 2.339

10.  Cerebral oligodendroglioma: prognostic factors and life history.

Authors:  P Celli; I Nofrone; L Palma; G Cantore; A Fortuna
Journal:  Neurosurgery       Date:  1994-12       Impact factor: 4.654

View more
  1 in total

1.  Favorable long-term outcome of low-grade oligodendrogliomas irrespective of 1p/19q status when treated without radiotherapy.

Authors:  Yasuo Iwadate; Tomoo Matsutani; Yuzo Hasegawa; Natsuki Shinozaki; Yoshinori Higuchi; Naokatsu Saeki
Journal:  J Neurooncol       Date:  2010-08-19       Impact factor: 4.130

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.